Francia Christopher 4
4 · Kubient, Inc. · Filed Jun 29, 2021
Insider Transaction Report
Form 4
Kubient, Inc.KBNT
Francia Christopher
Chief Product Officer
Transactions
- Sale
Common Stock
2021-06-23$5.43/sh−2,305$12,527→ 84,885 total - Exercise/Conversion
Common Stock
2021-06-23$2.97/sh+2,815$8,361→ 87,190 total - Exercise/Conversion
Employee Stock Option (right to buy)
2021-06-23−2,815→ 0 totalExercise: $2.97Exp: 2022-05-26→ Common Stock (2,815 underlying) - Sale
Common Stock
2021-06-23$5.37/sh−510$2,737→ 84,375 total
Footnotes (1)
- [F1]The Reporting Person was granted options to purchase 3,223 shares on May 26, 2017. The options vested in monthly installments over four years, beginning on May 26, 2018, at the rate of 1/4th of the total number of shares on the first anniversary of May 26, 2017 and 1/48th of the total number of shares each month thereafter. The Reporting Person resigned from employment with the Issuer effective March 31, 2021 and, as of such date, only 2,815 of the options originally granted to the Reporting Person were fully vested.